Anthracycline-refractory TNBC

Clinical trials for Anthracycline-refractory TNBC explained in plain language.

Never miss a new study

Get alerted when new Anthracycline-refractory TNBC trials appear

Sign up with your email to follow new studies for Anthracycline-refractory TNBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental triple combo for tough breast cancer shows early promise but trial stops short

Disease control Stopped early

This Phase 2 trial tested a combination of chemotherapy (docetaxel), an immunotherapy drug (pembrolizumab), and a gene therapy (IL-12) in 8 women with triple negative breast cancer that had stopped responding to standard anthracycline treatment. The goal was to see if the combina…

Matched conditions: ANTHRACYCLINE-REFRACTORY TNBC

Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

Anthracycline-refractory TNBC

Get alerted when new Anthracycline-refractory TNBC trials appear

Experimental triple combo for tough breast cancer shows early promise but trial stops short